Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1972 2
1973 3
1974 2
1975 2
1976 4
1977 1
1978 1
1979 2
1980 1
1981 3
1982 2
1983 3
1984 1
1985 2
1986 3
1987 1
1988 1
1989 3
1991 3
1992 4
1993 2
1994 7
1995 11
1996 8
1997 7
1998 3
1999 5
2000 6
2001 5
2002 9
2003 7
2004 2
2005 6
2006 8
2007 11
2008 5
2009 9
2010 3
2011 3
2012 4
2014 2
2015 3
2016 1
2017 3
2018 3
2019 8
2020 2
2021 3
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Results by year

Filters applied: . Clear all
Page 1
Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq Trial-ECOG-ACRIN EA6134.
Atkins MB, Lee SJ, Chmielowski B, Tarhini AA, Cohen GI, Truong TG, Moon HH, Davar D, O'Rourke M, Stephenson JJ, Curti BD, Urba WJ, Brell JM, Funchain P, Kendra KL, Ikeguchi AP, Jaslowski A, Bane CL, Taylor MA, Bajaj M, Conry RM, Ellis RJ, Logan TF, Laudi N, Sosman JA, Crockett DG, Pecora AL, Okazaki IJ, Reganti S, Chandra S, Guild S, Chen HX, Streicher HZ, Wolchok JD, Ribas A, Kirkwood JM. Atkins MB, et al. Among authors: okazaki ij. J Clin Oncol. 2023 Jan 10;41(2):186-197. doi: 10.1200/JCO.22.01763. Epub 2022 Sep 27. J Clin Oncol. 2023. PMID: 36166727 Free PMC article. Clinical Trial.
LAG-3: from molecular functions to clinical applications.
Maruhashi T, Sugiura D, Okazaki IM, Okazaki T. Maruhashi T, et al. Among authors: okazaki im. J Immunother Cancer. 2020 Sep;8(2):e001014. doi: 10.1136/jitc-2020-001014. J Immunother Cancer. 2020. PMID: 32929051 Free PMC article. Review.
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.
Miller JS, Soignier Y, Panoskaltsis-Mortari A, McNearney SA, Yun GH, Fautsch SK, McKenna D, Le C, Defor TE, Burns LJ, Orchard PJ, Blazar BR, Wagner JE, Slungaard A, Weisdorf DJ, Okazaki IJ, McGlave PB. Miller JS, et al. Among authors: okazaki ij. Blood. 2005 Apr 15;105(8):3051-7. doi: 10.1182/blood-2004-07-2974. Epub 2005 Jan 4. Blood. 2005. PMID: 15632206 Free article. Clinical Trial.
Stimulatory and Inhibitory Co-signals in Autoimmunity.
Okazaki T, Okazaki IM. Okazaki T, et al. Among authors: okazaki im. Adv Exp Med Biol. 2019;1189:213-232. doi: 10.1007/978-981-32-9717-3_8. Adv Exp Med Biol. 2019. PMID: 31758536 Review.
T-cell-intrinsic and -extrinsic regulation of PD-1 function.
Sugiura D, Shimizu K, Maruhashi T, Okazaki IM, Okazaki T. Sugiura D, et al. Among authors: okazaki im. Int Immunol. 2021 Nov 25;33(12):693-698. doi: 10.1093/intimm/dxab077. Int Immunol. 2021. PMID: 34596210 Review.
Vertebrate mono-ADP-ribosyltransferases.
Zolkiewska A, Okazaki IJ, Moss J. Zolkiewska A, et al. Among authors: okazaki ij. Mol Cell Biochem. 1994 Sep;138(1-2):107-12. doi: 10.1007/BF00928450. Mol Cell Biochem. 1994. PMID: 7898451 Review.
ADP-ribosylarginine hydrolases.
Takada T, Okazaki IJ, Moss J. Takada T, et al. Among authors: okazaki ij. Mol Cell Biochem. 1994 Sep;138(1-2):119-22. doi: 10.1007/BF00928452. Mol Cell Biochem. 1994. PMID: 7898453 Review.
192 results